STRUCTURE AND FUNCTION OF FERROCHELATASE

铁螯合酶的结构和功能

基本信息

  • 批准号:
    2190797
  • 负责人:
  • 金额:
    $ 10万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1995
  • 资助国家:
    美国
  • 起止时间:
    1995-09-30 至 1998-09-29
  • 项目状态:
    已结题

项目摘要

This is a Shannon Award providing partial support for the research projects that fall short of the assigned institute's funding range but are in the margin of excellence. The Shannon Award is intended to provide support to test the feasibility of the approach; develop further tests and refine research techniques; perform secondary analysis of available data sets; or conduct discrete projects that can demonstrate the PI's research capabilities or lend additional weight to an already meritorious application. The abstract below is taken from the original document submitted by the principal investigator. Heme is essential in almost every single aspect of cell function, as it is a required prosthetic group in proteins with very diversified functions. Ferrochelatase (protoheme ferrolyase, EC 4.99.1.1) catalyzes the insertion of ferrous ion into protoporphyrin IX forming the product protoheme IX and has been recognized as a key enzyme in heme biosynthesis since 1956. Unfortunately, for the past decades, research on ferrochelatase has been hindered by the difficultly in obtaining sufficient quantities of purified active enzyme, in part due to the association of ferrochelatase with membranes and the low abundance of ferrochelatase in mitochondria. Most of our knowledge concerning the active sites of ferrochelatase was derived from kinetic studies of chemically modified ferrochelatase and inhibition studies. More direct physical investigations, such as spectroscopic studies, were not possible due to the limited availability of purified proteins. This major hurdle has been overcome by one of our collaborators, Dr. G. C. Ferreira, who has successfully overexpressed the murine ferrochelatase in Escherichia coli. Most importantly, the recombinant enzyme is associated with the bacterial soluble fraction, facilitating the subsequent purification and manipulation of the enzyme. We now have essentially unlimited quantities of purified active ferrochelatase for spectroscopic and kinetic studies. Our preliminary EPR and Mossbauer spectroscopic studies of the recombinant enzyme reveal an important and surprising result. That is, mammalian ferrochelatase is a metalloenzyme containing a [2Fe-2S] cluster. These new developments have opened up many new avenues for ferrochelatase research. We therefore propose to use a combination of spectroscopic, chemical, biochemical, and molecular biological approaches to investigate the structure and function of ferrochelatase. In particular, we propose (1) to apply Mossbauer, EPR and NMR spectroscopy to characterize and to obtain structural information about the ferrous binding site and the [2Fe-2S] cluster, (2) to identify the amino-acid residues essential for ferrochelatase function using site-directed mutagenesis in combination with spectroscopic and kinetic investigations, and (3) to elucidate the mechanism of ferrochelatase employing rapid freeze-quench EPR and Mossbauer techniques. Since ferrochelatase uses iron as a substrate and our preliminary results established that it is an iron-containing enzyme, the proposed spectroscopic approach, a combination of Mossbauer and EPR techniques, is particularly suited for the studies of ferrochelatase. The proposed investigations are expected to yield characteristic physical properties and structural information concerning the substrate iron binding site and the 2[Fe-2S] clusters, and to provide detailed mechanistic information. Possible reaction intermediates may be trapped and characterized, and its rates of formation and decay will be determined. the proposed studies are also expected to shed light on the functional role of the [2Fe-2S] cluster in ferrochelatase and provide new insights in general into the role of iron sulfur clusters in proteins.
这是香农奖,为这项研究提供部分支持

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Boi-Hanh V. Huynh其他文献

Boi-Hanh V. Huynh的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Boi-Hanh V. Huynh', 18)}}的其他基金

MECHANISM OF FERRITIN FERROXIDATION AND MINERALIZATION
铁蛋白铁氧化和矿化机制
  • 批准号:
    2739253
  • 财政年份:
    1999
  • 资助金额:
    $ 10万
  • 项目类别:
MECHANISM OF FERRITIN FERROXIDATION AND MINERALIZATION
铁蛋白铁氧化和矿化机制
  • 批准号:
    6343059
  • 财政年份:
    1999
  • 资助金额:
    $ 10万
  • 项目类别:
MECHANISM OF FERRITIN FERROXIDATION AND MINERALIZATION
铁蛋白铁氧化和矿化机制
  • 批准号:
    6490265
  • 财政年份:
    1999
  • 资助金额:
    $ 10万
  • 项目类别:
MECHANISM OF FERRITIN FERROXIDATION AND MINERALIZATION
铁蛋白铁氧化和矿化机制
  • 批准号:
    6138700
  • 财政年份:
    1999
  • 资助金额:
    $ 10万
  • 项目类别:
Biosynthesis and Novel Functions of Fe-S Clusters
Fe-S团簇的生物合成和新功能
  • 批准号:
    6325357
  • 财政年份:
    1992
  • 资助金额:
    $ 10万
  • 项目类别:
OXYGEN ACTIVATION BY NON HEME FE PROTEINS
非血红素铁蛋白的氧激活
  • 批准号:
    2770980
  • 财政年份:
    1992
  • 资助金额:
    $ 10万
  • 项目类别:
NOVEL REDOX PROTEINS FROM SULFATE REDUCING BACT
来自硫酸盐还原菌的新型氧化还原蛋白
  • 批准号:
    3306756
  • 财政年份:
    1992
  • 资助金额:
    $ 10万
  • 项目类别:
NOVEL REDOX PROTEINS FROM SULFATE REDUCING BACT
来自硫酸盐还原菌的新型氧化还原蛋白
  • 批准号:
    3306758
  • 财政年份:
    1992
  • 资助金额:
    $ 10万
  • 项目类别:
Biosynthesis and Novel Function of Fe-S clusters
Fe-S团簇的生物合成和新功能
  • 批准号:
    6918157
  • 财政年份:
    1992
  • 资助金额:
    $ 10万
  • 项目类别:
Biosynthesis and Novel Function of Fe-S clusters
Fe-S团簇的生物合成和新功能
  • 批准号:
    7217335
  • 财政年份:
    1992
  • 资助金额:
    $ 10万
  • 项目类别:

相似海外基金

Cystathionine Gamma Lyase (CSE) and Hydrogen Sulfide Regulation of Vascular Aging
胱硫醚γ裂解酶 (CSE) 和硫化氢对血管老化的调节
  • 批准号:
    10715408
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
Development of amine-dehydrogenase and lyase biocatalysts for the sustainable manufacturing of unnatural chiral amino acids and amino alcohols
开发胺脱氢酶和裂解酶生物催化剂,用于可持续生产非天然手性氨基酸和氨基醇
  • 批准号:
    2870226
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
    Studentship
Deciphering the roles of cystathionine gamma-lyase/H2S system in Fe-S protein biogenesis and iron homeostasis
解读胱硫醚γ-裂解酶/H2S系统在Fe-S蛋白生物发生和铁稳态中的作用
  • 批准号:
    RGPIN-2022-05369
  • 财政年份:
    2022
  • 资助金额:
    $ 10万
  • 项目类别:
    Discovery Grants Program - Individual
Neuroprotective actions of cystathionine g-lyase through gasotransmitter hydrogen sulfide signaling
胱硫醚 G-裂解酶通过气体递质硫化氢信号传导的神经保护作用
  • 批准号:
    10614053
  • 财政年份:
    2022
  • 资助金额:
    $ 10万
  • 项目类别:
Neuroprotective actions of cystathionine g-lyase through gasotransmitter hydrogen sulfide signaling
胱硫醚 G-裂解酶通过气体递质硫化氢信号传导的神经保护作用
  • 批准号:
    10445502
  • 财政年份:
    2022
  • 资助金额:
    $ 10万
  • 项目类别:
Metabolic regulation and inhibition of ATP-citrate lyase
ATP-柠檬酸裂解酶的代谢调节和抑制
  • 批准号:
    10588229
  • 财政年份:
    2022
  • 资助金额:
    $ 10万
  • 项目类别:
Targeting ATP-citrate lyase (ACLY) to overcome therapy resistance in breast cancer and melanoma
靶向 ATP-柠檬酸裂解酶 (ACLY) 以克服乳腺癌和黑色素瘤的治疗耐药性
  • 批准号:
    10580197
  • 财政年份:
    2022
  • 资助金额:
    $ 10万
  • 项目类别:
Metabolic regulation and inhibition of ATP-citrate lyase
ATP-柠檬酸裂解酶的代谢调节和抑制
  • 批准号:
    10444160
  • 财政年份:
    2022
  • 资助金额:
    $ 10万
  • 项目类别:
Validating absolute lymphocyte count and plasma sphingosine-1-phosphate as disease biomarkers of sphingosine phosphate lyase insufficiency syndrome in anticipation of a pyridoxine clinical trial
验证绝对淋巴细胞计数和血浆 1-磷酸鞘氨醇作为磷酸鞘氨醇裂解酶不足综合征的疾病生物标志物,以期待吡哆醇临床试验
  • 批准号:
    10515118
  • 财政年份:
    2022
  • 资助金额:
    $ 10万
  • 项目类别:
Validating absolute lymphocyte count and plasma sphingosine-1-phosphate as disease biomarkers of sphingosine phosphate lyase insufficiency syndrome in anticipation of a pyridoxine clinical trial
验证绝对淋巴细胞计数和血浆 1-磷酸鞘氨醇作为磷酸鞘氨醇裂解酶不足综合征的疾病生物标志物,以期待吡哆醇临床试验
  • 批准号:
    10705139
  • 财政年份:
    2022
  • 资助金额:
    $ 10万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了